Bone 34:609–618CrossRefPubMed 10. Kasukawa Y, Miyakoshi N, Itoi E, Tsuchida T, Tamura Y, Kudo T, Suzuki K, Seki A, Sato K (2004) Effects of h-PTH on cancellous bone mass, connectivity, and bone strength in OICR-9429 mw ovariectomized rats with and without sciatic-neurectomy. J Orthop Res 22:457–464CrossRefPubMed 11. Zhang KQ, Chen JW, Li QN, Li GF, Tian XY, Huang LF, Bao LH, Wang ML (2002) Effect of intermittent injection of recombinant human parathyroid hormone on bone histomorphometry of
ovariectomized rats. Acta Pharmacol Sin 23:659–662PubMed 12. Lane NE, Yao W, Kinney JH, Modin G, Balooch M, Wronski TJ (2003) Both hPTH(1–34) and bFGF increase trabecular bone Target Selective Inhibitor Library datasheet mass in osteopenic rats but they have different effects on trabecular bone architecture. J Bone Miner Res 18:2105–2115CrossRefPubMed
13. Nozaka K, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H, Shimada Y (2008) Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone 42:90–97CrossRefPubMed 14. Iwaniec UT, Moore K, Rivera MF, Myers SE, Vanegas SM, Wronski TJ (2007) A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats. Osteoporos Int 18:351–362CrossRefPubMed 15. Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY (2007) Daily treatment of aged ovariectomized rats with human parathyroid hormone Fossariinae (1–84) for 17-AAG 12 months reverses bone loss and enhances trabecular and cortical bone strength. Bone 41:321–330CrossRefPubMed 16. Ejersted C, Andreassen TT, Hauge E-M, Melsen F, Oxlund H (1995) Parathyroid hormone (1–34) increases vertebral bone mass, compressive strength, and quality in old rats. Bone 17:507–511CrossRefPubMed 17. Gasser JA (1997) Quantitative assessment of bone mass and geometry by pQCT in rats in vivo and site specificity
of changes at different skeletal sites. J Jpn Soc Bone Morphometry 7:107–114 18. Kneissel M, Boyde A, Gasser JA (2001) Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1–34). Bone 28:237–250CrossRefPubMed 19. Fox J, Miller MA, Newman MK, Turner CH, Recker RR, Smith SY (2007) Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1–84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine. J Bone Miner Res 22:260–273CrossRefPubMed 20. Jerome CP, Burr DB, Van Bibber T, Hock JM, Brommage R (2001) Treatment with human parathyroid hormone (1–34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 28:150–159CrossRefPubMed 21.
Related posts:
- Methods useful in the treatment of bone resorption diseases
- 2000] Moreover, age-related bone loss is directly correlated wit
- JAK Inhibitors especially in the age-related osteoporotic bone
- J Bone Miner Res 14:1449–1456PubMedCrossRef 20 Marshall D, Johne
- Also, the different study durations are likely to play a role, as